<DOC>
	<DOCNO>NCT01069861</DOCNO>
	<brief_summary>Sildenafil efficacious newborn persistent pulmonary hypertension use reduce need inhale nitric oxide .</brief_summary>
	<brief_title>Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension ( PPHN )</brief_title>
	<detailed_description>Letter investigator date 18 June 2012 study terminate . Study terminate due evolve widespread use standard care , relevance study question . No safety reason issue .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>72 hour age ; &gt; = 34 week gestational age . Persistent Pulmonary Hypertension Newborn Hypoxic respiratory failure associate : 1 . Idiopathic PPHN 2 . Meconium aspiration syndrome 3 . Sepsis 4 . Pneumonia Oxygenation Index ( OI ) &gt; 15 &lt; 60 calculated Patients already receive inhale nitric oxide ( iNO ) referral . Prior immediate need full Cardio Pulmonary Resuscitation Extracorporeal Membrane Oxygenation ( ECMO ) . Life threaten lethal congenital anomaly . Large leave right intracardiac ductal shunting ( diagnosed echocardiogram admission GOSH ) . Clinically significant active seizure per clinical judgment . Bleeding diathesis per clinical judgment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Hours</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>PPHN</keyword>
	<keyword>neonate</keyword>
	<keyword>sildanefil IV</keyword>
</DOC>